Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG executive Daniel O'Day as its new chief executive, tapping an industry veteran to fill a management vacuum.
Reuters: Business News, Reuters: Business
Mon, 12/10/2018 - 12:03am
Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG executive Daniel O'Day as its new chief executive, tapping an industry veteran to fill a management vacuum.